Drug Ther Bull 2002 May;40(5):38-40
In the UK, around 10-12 in every 10,000 people have multiple sclerosis, typical features of which include weakness, ataxia, spasticity and sensory loss.
By comparison, around 16-18 in every 10,000 have Parkinson's disease, a condition typified by rigidity, bradykinesia, tremor and postural instability.
Both conditions can limit function with, for example, nearly 25% of patients with multiple sclerosis and about 10% of those with Parkinson's disease being dependent on a wheelchair.
Physiotherapy is widely used as part of a multidisciplinary approach to the management of multiple sclerosis, while 7-38% of people with Parkinson's disease are referred for physiotherapy.
Here, we review the evidence for physiotherapy in the management of patients with either condition.